Back
CRISPR Therapeutics AG Stock Price Chart
Sponsored
CRSP
Sponsored
Investing Today: The Best Way To Grow A Small Account
In his free guide, expert Joe Duffy reveals... click here to read on...
Buy
56
CRSP
CRISPR Therapeutics AG
Last Price:
50.76
Seasonality Move:
35.78%
7 Day Trial
ALL ACCESS PASS
$
7
This New Investment Could Pay You $7,013 Every Month
Click HERE to discover the NEW $7,013 per month income secret.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.13 | Buy |
20-day SMA: | 47.45 | Buy |
50-day SMA: | 47.16 | Buy |
200-day SMA: | 58.25 | Sell |
8-day EMA: | 48.42 | Buy |
20-day EMA: | 47.83 | Buy |
50-day EMA: | 48.23 | Buy |
200-day EMA: | 53.92 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.43 | Buy |
Relative Strength Index (14 RSI): | 59.39 | Buy |
Chaikin Money Flow: | 2128956 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.6 - 48.76) | Buy |
Bollinger Bands (100): | (45.7 - 56.42) | Sell |
CRISPR Therapeutics AG Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 50.76 while CRSP 8-day simple moving average is 48.13, which is a Buy signal.
- The stock price of CRSP is 50.76 while CRISPR Therapeutics AG 20-day SMA is 47.45, which makes it a Buy.
- CRISPR Therapeutics AG 50-day simple moving average is 47.16 while CRSP share price is 50.76, making it a Buy technically.
- CRSP stock price is 50.76 and CRISPR Therapeutics AG 200-day simple moving average is 58.25, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Buy
56
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Buy
The current CRISPR Therapeutics AG [CRSP] share price is $50.76. The Score for CRSP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.32B
Price in USD:
50.76
Share Volume:
2.23M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
43.42
Buy
56
CRISPR Therapeutics AG (CRSP)
is a Buy
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 50.76 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is not overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 50.76 while CRSP 8-day exponential moving average is 48.42, which is a Buy signal.
- The stock price of CRSP is 50.76 while CRISPR Therapeutics AG 20-day EMA is 47.83, which makes it a Buy.
- CRISPR Therapeutics AG 50-day exponential moving average is 48.23 while CRSP share price is 50.76, making it a Buy technically.
- CRSP stock price is 50.76 and CRISPR Therapeutics AG 200-day simple moving average is 53.92, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.69 per share, and an increase next year of $0.35 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is 0.43, suggesting CRISPR Therapeutics AG is a Buy
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 59.39, which suggest CRISPR Therapeutics AG is overbought
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (45.6 - 48.76), which suggest CRISPR Therapeutics AG is a Sell
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (45.7 - 56.42), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.